Search Results

Isofol Medical AB, announced that the company’s interim report for January-September 2022.

Isofol Medical AB, announced that the company’s interim report for January-June 2022 is now available on the company’s website.

Isofol Medical AB, announced that Chief Executive Officer Dr. Ulf Jungnelius M.D. and Isofol’s Board of Directors have agreed that Ulf will step down as CEO of Isofol on June 1, 2023.

Emboline, Inc. announced the acquisition of a significant portfolio of key intellectual property from SWAT Medical AB for aortic embolic protection during interventional cardiology procedures.

AB Science SA announced the publication of an article in Muscle & Nerve, a peer-reviewed medical journal covering neuromuscular medicine.

atsec AB Stockholm, Sweden is thrilled to announce: We are the first IEEE Authorized Testing Facility! This press release features multimedia.

Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) (“Isofol”), will publish the company’s results for the third quarter of 2022 on Friday, November 11, 2022.

Vitrolife AB has completed the acquisition of eFertility as previously communicated in the press release on 2 May 2024.

Medivir AB announces that the number of shares and votes in Medivir has changed during June 2024 as a result of the issue of 1,700,000 shares of series C and the reclassification of 114 587 shares of series C to ordinary shares which was carried out as a part of the implementation of the incentive program resolved by the general meeting on 7 May 2024.

Isofol Medical AB, will publish the company’s results for the second quarter of 2022 on Tuesday, August 23, 2022.